FindCure Biosciences (ZhongShan) Co., Ltd.
5 clinical trials · Sponsor
◉ Watch FindCure Biosciences (ZhongShan) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer (NCT07542379) | FindCure Biosciences (ZhongShan) Co., Ltd. | 2026-04-01 |
| The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors (NCT07459283) | FindCure Biosciences (ZhongShan) Co., Ltd. | 2026-04-01 |
| The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer (NCT07468708) | FindCure Biosciences (ZhongShan) Co., Ltd. | 2026-03-09 |
| A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors (NCT06499350) | FindCure Biosciences (ZhongShan) Co., Ltd. | 2024-11-13 |
| A Study of Axl Inhibitor FC084CSA in Patients With Advanced Malignant Solid Tumors (NCT06231550) | FindCure Biosciences (ZhongShan) Co., Ltd. | 2023-03-01 |
Track FindCure Biosciences (ZhongShan) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.